Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy.

Munk, Marion R

Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy. [electronic resource] - JAMA ophthalmology Jul 2014 - 899-901 p. digital

Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't

2168-6173

10.1001/jamaophthalmol.2014.409 doi


Adenocarcinoma--drug therapy
Aged
Autoantibodies--blood
Autoantigens--immunology
Electroretinography
Erlotinib Hydrochloride
HSP90 Heat-Shock Proteins--antagonists & inhibitors
Humans
Infusions, Intravenous
Isoxazoles--administration & dosage
Lung Neoplasms--drug therapy
Male
Night Blindness--chemically induced
Paraneoplastic Syndromes, Ocular--chemically induced
Phosphopyruvate Hydratase--immunology
Quinazolines--administration & dosage
Resorcinols--administration & dosage
Retina--drug effects
Tomography, Optical Coherence
Visual Acuity--physiology